Investment in research and development
First written in FY2017-Q3. . Latest entry: FY2026.
48 other companies' latest entry also says "Other".
- FY2026Full-year R&D expenses: ¥683 millionAnnual report
「R&D spending for the consolidated fiscal year was ¥683 million.」
The Company disclosed full-year R&D spending of ¥683 million. - FY2026-H1Interim R&D spending: ¥327 millionAnnual report
「R&D spending for the interim consolidated accounting period was ¥327 million. There were no material changes in the status of the Company's R&D activities during the interim consolidated accounting period.」
The Company disclosed R&D spending of ¥327 million for the interim consolidated accounting period and stated that there were no material changes in the status of its R&D activities. - FY2025-H1Interim R&D spending: ¥325 millionAnnual report
「R&D spending for the interim consolidated accounting period was ¥325 million. There were no material changes in the status of the Company's R&D activities during the interim consolidated accounting period.」
The Company disclosed R&D spending of ¥325 million for the interim consolidated accounting period and stated that there were no material changes in the status of its R&D activities. - FY2024Full-year R&D spending: ¥654 millionAnnual report
「R&D spending for the consolidated fiscal year was ¥654 million.」
The Company disclosed full-year R&D spending of ¥654 million. - FY2024-Q2Nine-month cumulative R&D spending: ¥491 millionAnnual report
「R&D spending for the nine months ended was ¥491 million. There were no material changes in the status of the Company's R&D activities during the nine months ended.」
The Company disclosed consolidated nine-month cumulative R&D spending of ¥491 million and stated that there were no material changes in the status of its R&D activities. - FY2024-Q1Six-month cumulative R&D spending: ¥317 millionAnnual report
「R&D spending for the six months ended was ¥317 million. There were no material changes in the status of the Company's R&D activities during the six months ended.」
The Company disclosed consolidated six-month cumulative R&D spending of ¥317 million and stated that there were no material changes in the status of its R&D activities. - FY2023-Q4First-quarter R&D spending: ¥157 millionAnnual report
「R&D spending for the three months ended was ¥157 million. There were no material changes in the status of the Company's R&D activities during the three months ended.」
The Company disclosed consolidated first-quarter cumulative R&D spending of ¥157 million and stated that there were no material changes in the status of its R&D activities. - FY2023Full-year R&D spending: ¥503 millionAnnual report
「R&D spending for the consolidated fiscal year was ¥503 million.」
The Company disclosed FY2023 full-year R&D spending of ¥503 million. - FY2023-Q2Nine-month cumulative R&D spending: ¥368 millionAnnual report
「R&D spending for the nine months ended was ¥368 million. There were no material changes in the status of the Company's R&D activities during the nine months ended.」
The Company disclosed consolidated nine-month cumulative R&D spending of ¥368 million and stated that there were no material changes in the status of its R&D activities. - FY2023-Q1Six-month cumulative R&D spending: ¥249 millionAnnual report
「R&D spending for the six months ended was ¥249 million. There were no material changes in the status of the Company's R&D activities during the six months ended.」
The Company disclosed consolidated six-month cumulative R&D spending of ¥249 million and stated that there were no material changes in the status of its R&D activities. - FY2022-Q4First-quarter R&D spending: ¥118 millionAnnual report
「R&D spending for the three months ended was ¥118 million. There were no material changes in the status of the Company's R&D activities during the three months ended.」
The Company disclosed R&D spending of ¥118 million for the first quarter from April to June 2022 and stated that there were no material changes in the status of its R&D activities. - FY2022Full-year R&D spending: ¥411 millionAnnual report
「R&D spending for the consolidated fiscal year was ¥411 million.」
The Company disclosed full-year R&D spending of ¥411 million. - FY2022-Q2Six-month cumulative R&D spending: ¥295 millionAnnual report
「R&D spending for the six months ended was ¥295 million. There were no material changes in the status of the Company's R&D activities during the six months ended.」
The Company disclosed consolidated six-month cumulative R&D spending of ¥295 million and stated that there were no material changes in the status of its R&D activities. - FY2022-Q1First-quarter R&D spending: ¥153 millionAnnual report
「R&D spending for the three months ended was ¥153 million. There were no material changes in the status of the Company's R&D activities during the three months ended.」
The Company disclosed first-quarter cumulative R&D spending of ¥153 million and stated that there were no material changes in the status of its R&D activities. - FY2021-Q3Nine-month cumulative R&D spending: ¥398 millionAnnual report
「R&D spending for the nine months ended was ¥398 million. There were no material changes in the status of the Company's R&D activities during the nine months ended.」
The Company disclosed nine-month cumulative R&D spending of ¥398 million and stated that there were no material changes in the status of its R&D activities. - FY2021-Q2Six-month cumulative R&D spending: ¥267 millionAnnual report
「R&D spending for the six months ended was ¥267 million. There were no material changes in the status of the Company's R&D activities during the six months ended.」
The Company disclosed consolidated six-month cumulative R&D spending of ¥267 million and stated that there were no material changes in the status of its R&D activities. - FY2021-Q1First-quarter R&D spending: ¥126 millionAnnual report
「R&D spending for the three months ended was ¥126 million. There were no material changes in the status of the Company's R&D activities during the three months ended.」
The Company disclosed first-quarter cumulative R&D spending of ¥126 million and stated that there were no material changes in the status of its R&D activities. - FY2020Full-year R&D spending: ¥456 millionAnnual report
「R&D spending for the consolidated fiscal year was ¥456 million.」
The Company disclosed full-year R&D spending of ¥456 million. - FY2020-Q3Nine-month cumulative R&D spending: ¥348 millionAnnual report
「R&D spending for the nine months ended was ¥348 million. There were no material changes in the status of the Company's R&D activities during the nine months ended.」
The Company disclosed nine-month cumulative R&D spending of ¥348 million and stated that there were no material changes in the status of its R&D activities. - FY2020-Q2Second-quarter cumulative R&D expenses: ¥230 millionAnnual report
「R&D spending for the six months ended was ¥230 million. There were no material changes in the status of the Company's R&D activities during the six months ended.」
The Company disclosed R&D spending of ¥230 million for the six months ended and stated that there were no material changes in the status of its R&D activities. - FY2020-Q1Research and development expenses of ¥111 million for the cumulative first quarterAnnual report
「R&D expenses during the three months ended June 2023 were ¥111 million. There were no material changes in the status of the company’s R&D activities during the three months ended June 2023.」
The company disclosed cumulative R&D expenses of ¥111 million for the first quarter and stated that there had been no material changes in the status of its R&D activities. - FY2019Full-year R&D expenses: ¥420 millionAnnual report
「R&D expenses for the consolidated fiscal year were ¥420 million.」
The company disclosed full-year R&D expenses of ¥420 million. - FY2019-Q3Third-quarter cumulative R&D expenses: ¥321 millionAnnual report
「R&D expenses during the nine months ended December 2023 were ¥321 million. There were no material changes in the status of the company’s R&D activities during the nine months ended December 2023.」
The company disclosed R&D expenses of ¥321 million for the nine months ended December 2023 and stated that there had been no material changes in the status of its activities. - FY2019-Q2Second-quarter cumulative R&D expenses: ¥217 millionAnnual report
「R&D expenses during the six months ended September 2023 were ¥217 million. There were no material changes in the status of the company’s R&D activities during the six months ended September 2023.」
The company disclosed R&D expenses of ¥217 million for the six months ended September 2023 and stated that there had been no material changes in the status of its activities. - FY2019-Q1First-quarter cumulative R&D expenses: ¥109 millionAnnual report
「R&D expenses during the three months ended June 2023 were ¥109 million. There were no material changes in the status of the company’s R&D activities during the three months ended June 2023.」
The company disclosed R&D expenses of ¥109 million for the three months ended June 2023 and stated that there had been no material changes in the status of its activities. - FY2018Full-year R&D expenses: ¥440 millionAnnual report
「R&D expenses for the consolidated fiscal year were ¥440 million.」
The company disclosed full-year R&D expenses of ¥440 million. - FY2018-Q3Third-quarter cumulative R&D expenses: ¥325 millionAnnual report
「R&D expenses during the nine months ended December 2023 were ¥325 million. There were no material changes in the status of the company’s R&D activities during the nine months ended December 2023.」
The company disclosed R&D expenses of ¥325 million for the nine months ended December 2023 and stated that there had been no material changes in the status of its R&D activities. - FY2018-Q2Second-quarter cumulative R&D expenses: ¥213 millionAnnual report
「R&D expenses during the six months ended September 2023 were ¥213 million. There were no material changes in the status of the company’s R&D activities during the six months ended September 2023.」
The company disclosed R&D expenses of ¥213 million for the six months ended September 2023 and stated that there had been no material changes in the status of its R&D activities. - FY2018-Q1Research and development expenses of ¥111 million for the cumulative first quarterAnnual report
「R&D expenses during the three months ended June 2023 were ¥111 million. There were no material changes in the status of the company’s R&D activities during the three months ended June 2023.」
The company disclosed R&D expenses of ¥111 million for the first quarter and stated that there had been no material changes in the status of its activities. - FY2017Full-year R&D expenses: ¥423 millionAnnual report
「R&D expenses for the consolidated fiscal year were ¥423 million.」
The company disclosed full-year R&D expenses of ¥423 million, updated from ¥311 million for the nine months ended December of the previous fiscal year. - FY2017-Q3First statedAnnual report
「R&D expenses during the nine months ended December 2023 were ¥311 million. There were no material changes in the status of the company’s R&D activities during the nine months ended December 2023.」
The company disclosed R&D expenses of ¥311 million for the nine months ended December 2023 and stated that there had been no material changes in the status of its activities.